Professor Sarah C Darby named Fellow of the Royal Society
Sarah, who is Professor of Medical Statistics at the Nuffield Department of Population Health, University of Oxford, is one of 51 eminent scientists to gain the honour for her exceptional contribution to science.
She is a statistical epidemiologist leading work at the Clinical Trial Service Unit to evaluate the benefits and risks of treatments for cancer.
Ten new Foreign Members and one Honorary Fellow have also been elected.
Venki Ramakrishnan, President of the Royal Society, said it was a “great honour” to welcome the new Fellows and Foreign Members.
“Over the course of the Royal Society’s vast history, it is our Fellowship that has remained a constant thread and the substance from which our purpose has been realised: to use science for the benefit of humanity,” he said.
“This year’s newly elected Fellows and Foreign Members of the Royal Society embody this, being drawn from diverse fields of enquiry – epidemiology, geometry, climatology – at once disparate, but also aligned in their pursuit and contributions of knowledge about the world in which we live, and it is with great honour that I welcome them as Fellows of the Royal Society.”
Research conducted by Sarah and her team has included examining the benefits and risks of radiotherapy in breast cancer patients, which has allowed analysis and comparison of the likely absolute benefit versus the likely absolute risk for individual patients, allowing the possibility for patients to be assessed as to whether they are best suited for standard radiotherapy, no radiotherapy or advanced techniques.
The team has also studied the risks of heart disease after exposure to radiation, the risk of invasive breast cancer after a diagnosis of ductal carcinoma in situ, the risk of lung cancer from residential radon, and the risks of cancer after CT scans in young people.